首页 | 本学科首页   官方微博 | 高级检索  
     

低剂量阿托伐他汀对冠心病患者血脂及C-反应蛋白的影响
引用本文:陈国庆,薛杰韬,许先继,梁碧,丁英,陈康. 低剂量阿托伐他汀对冠心病患者血脂及C-反应蛋白的影响[J]. 现代医院, 2007, 7(6): 42-43
作者姓名:陈国庆  薛杰韬  许先继  梁碧  丁英  陈康
作者单位:湛江南海西部石油公司职工医院,广东湛江,524057
摘    要:目的低剂量阿托伐他汀对冠心病患者血脂及血清C-反应蛋白浓度的影响。方法将98例稳定性冠心病伴高脂血症患者随机分为治疗组53例和对照组45例,在常规治疗的基础上治疗组口服阿托伐他汀(5mg/d),对照组不加降脂药物,疗程均为6w。结果疗程结束后治疗组血脂指标及C-反应蛋白(CRP)改善情况均明显优于对照组,两组间结果具有显著性差异(p<0.05)。结论较低剂量阿托伐他汀对冠心病患者具有良好的降脂效应,且能有效降低患者的CRP,安全性良好。

关 键 词:阿托伐他汀  血脂  C-反应蛋白  冠心病

EXPLORATION ON EFFECT OF LOW DOSE ATORVASTATIN ON BLOOD LIPID AND CREACTIVE PROTEIN IN CORONARY HEART DISEASE
CHEN Guoqing, XUE Jietao, XU Xianji, et al. EXPLORATION ON EFFECT OF LOW DOSE ATORVASTATIN ON BLOOD LIPID AND CREACTIVE PROTEIN IN CORONARY HEART DISEASE[J]. Modern Hospital, 2007, 7(6): 42-43
Authors:CHEN Guoqing   XUE Jietao   XU Xianji   et al
Abstract:Objective To research the influence of the low dose atorvastatin on blood lipid and C-reactive protein(CRP)in elderly coronary heart disease.Methods 98 patients of stable coronary heart disease with hyperlipidemia were diviced to the treated group and the control group.The treated group was oral administration with atorvastatin for 6 weeks,measuring their blood lipid and blood CRP before and after treatment,then to analyse them with statistics.Results After 6 weeks of treatment,the patients' plasma levels of TC,TG,LDL-C and CRP were significantly decreased(p<0.05).Conclusion The low dose atorvastatin can reduce the blood liqid and CRP safely of elderly patients of stable coronary heart disease with hyperlipidemia.
Keywords:atorvastatin   blood liqid   C - reactive protein   elderly coronary heart disease
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号